ChartRow logo
Sign in
HALO
Halozyme Therapeutics Inc.Stock · Health Care
$100.67−$1.12 (-1.10%)as of market close, Aug 13, 2026
☾ After hours:$100.67+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

How Halozyme Therapeutics makes money

Period

How does Halozyme Therapeutics make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Halozyme Therapeutics Inc. · FY2025 · year ended 2025-12-31
Revenue$1.4BGross profit$1.2B · 84%Cost of revenue$229M · 16%Operating income$469M · 34%Operating expenses$699M · 50%R&D$81M · 6%SG&A$207M · 15%Other opex$410M · 29%Net income$317M · 23%Income tax$150M · 11%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.